Keratoconus patients more likely to develop sleep apnoea

Article

Keratoconus patients are more likely to develop sleep apnoea

Keratoconus patients are more likely to develop sleep apnoea, states a paper in the Journal of Cornea and External Disease.

Dr Michael Saidel, Section of Ophthalmology, University of Chicago, Illinois, USA, led a team that evaluated 92 keratoconus patients and 92 control patients. Each patient was classified as being high or low risk for sleep apnoea after answering the Berlin Questionnaire (BQ). The risk factors linked to high risk sleep apnoea was identified using logistic regression.

Out of the keratoconus patients questioned, 18 had a positive known sleep apnoea history and 49 were identified as high risk by the results of the BQ. Six of the 92 control patients had a positive known sleep apnoea history and 25 were identified as high risk.

In the control patients' age, body mass index and family history of sleep apnoea were the major risk factors for sleep apnoea. However, in keratoconus patients body mass index was the only risk factor for sleep apnoea.

The study results suggest that ophthalmologists should consider screening keratoconus patients for sleep apnoea.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.